A meta-analysis of pharmacotherapy for social anxiety disorder: an examination of efficacy, moderators, and mediators
The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: Social anxiety disorder (SAD) is among the most prevalent mental disorders, associated with impaired functioning and poor quality of life. Pharmacotherapy is the most widely utilized treatment option. The current study provides an updated meta-analytic review of the efficacy of pharmacotherapy and examines moderators and mediators of treatment efficacy. Areas Covered: A comprehensive search of the current literature yielded 52 randomized, pill placebo-controlled trials of pharmacotherapy for adults diagnosed with SAD. Data on potential mediators of treatment outcome were collected, as well as data necessary to calculate pooled correlation matrices to compute indirect effects. Expert Opinion: The overall effect size of pharmacotherapy for SAD is small to medium (Hedges' g = 0.41). Effect sizes were not moderated by age, sex, length of treatment, initial severity, risk of study bias, or publication year. Furthermore, reductions in symptoms mediated pharmacotherapy's effect on quality of life. Support was found for reverse mediation. Future directions may include sustained efforts to examine treatment mechanisms of pharmacotherapy using rigorous longitudinal methodology to better establish temporal precedence.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although pharmacotherapy is effective for SAD (Curtiss et al. 2017), cognitivebehavioral therapy (CBT) is considered the gold-standard treatment (Rodebaugh et al. 2004).”
From Trial-Based Cognitive Therapy: Efficacy of a New CBT Approach for Treating Social Anxiety Disorder with Comorbid Depression. (2018) · cites this paper as Curtiss et al. 2017
Citations
Cites
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.593 · Cited by 20,391
Duval, S., & Tweedie, R. (2000) · Biometrics · doi:10.1111/j.0006-341x.2000.00455.x · Cited by 14,099 · cited 1×
“Using the Trim and Fill method [71], we determined that nine studies would need to fall to the left of the mean (i.”
Method(2000) · Cited by 9,198
The file drawer problem and tolerance for null results.
Rosenthal, R. (1979) · Psychological Bulletin · doi:10.1037/0033-2909.86.3.638 · Cited by 9,068 · cited 1×
“was conducted to address the file drawer problem [69, 70].”
MethodMeta-Analytic Procedures for Social Research
Rosenthal, R. (1991) · doi:10.4135/9781412984997 · Cited by 4,635 · cited 2×
“the fail-safe N) exceeds 5K + 10, the effect is considered robust [13].”
BackgroundMethodMeta-Analytic Procedures for Social Research.
Metcalfe, A., & Rosenthal, R. (1994) · The Statistician · doi:10.2307/2348600 · Cited by 4,249
A Fail-Safe N for Effect Size in Meta-Analysis
Orwin, R. G. (1983) · Journal of Educational Statistics · doi:10.2307/1164923 · Cited by 2,064 · cited 1×
“was conducted to address the file drawer problem [69, 70].”
MethodGu, J., Strauss, C., Bond, R., & Cavanagh, K. (2015) · Clinical Psychology Review · doi:10.1016/j.cpr.2015.01.006 · Cited by 1,712 · cited 1×
“If a study did not explicitly report correlation matrices, then means, standard deviations, t-statistics, F-statistics, and effect sizes were extracted to compute correlation coefficients [16,17].”
MethodHoffman, S. G., & Smits, J. A. J. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0415 · Cited by 1,420 · cited 1×
“Although cognitive behavior therapy (CBT) is regarded as one of the most efficacious treatments for SAD [5,6], pharmacological interventions are more prevalent and widely utilized.”
BackgroundSelf-citationQuality of Life in Individuals With Anxiety Disorders
Mendlowicz, M. V., & Stein, M. B. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.5.669 · Cited by 955 · cited 2×
“symptoms [74], as the presence of some symptoms (e.”
BackgroundResult
Research works printed but not linked: 3
- Borenstein M, 1999, Comprehensive meta-analysis: A computer program for research synthesis
- 10.1007/BF02900196 · DOI
- Hofmann SG, 2013, Biol Mood Anxiety Disord, 3, 1
Cited by
Penninx, B. W., Pine, D. S., Holmes, E. A., & Reif, A. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00359-7 · Cited by 740
Leichsenring, F., Steinert, C., Rabung, S., & Ioannidis, J. P. A. (2022) · World Psychiatry · doi:10.1002/wps.20941 · Cited by 485
Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options
Garakani, A., Murrough, J. W., Freire, R. C., Thom, R. P., Larkin, K., Buono, F. D., & Iosifescu, D. V. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.595584 · Cited by 440
“They are not FDA-approved for anxiety disorders but may be considered in patients with SAD who are non-responsive to SSRIs (21).”
BackgroundLeichsenring, F., & Leweke, F. (2017) · New England Journal of Medicine · doi:10.1056/nejmcp1614701 · Cited by 256
Pharmacotherapy for social anxiety disorder (SAnD)
Williams, T., Hattingh, C. J., Kariuki, C. M., Tromp, S. A., van Balkom, A. J., Ipser, J. C., & Stein, D. J. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001206.pub3 · Cited by 84
Metadata
- Authors
- Curtiss, J., Andrews, L., Davis, M., Smits, J., & Hofmann, S. G.
- Affiliations
- Boston University (US)
- The University of Texas at Austin (US)
- Corresponding author
- Hofmann, Stefan G.
- Venue
- Expert Opinion on Pharmacotherapy
- Publisher
- Informa UK Limited
- Published
- 2017-02
- Volume
- 18
- Issue
- 3
- Pages
- 243-251
- ISSN
- 1465-6566 (ISSN-L)
- 1744-7666
- OpenAlex
- W2577035876
- Cited by
- 46
- References
- 77
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 9 · 2023: 5 · 2022: 4 · 2021: 7 · 2020: 4 · 2019: 5 · 2018: 6 · 2017: 2
- FWCI
- 0.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Expert Opinion on Pharmacotherapy (publishedVersion)
- PubMed (publishedVersion)
- OpenBU (Boston University) (submittedVersion)
- Funders
- National Center for Complementary and Integrative Health (R01AT007257)
- National Institute of Mental Health (K23MH100259, R01MH099021, R21MH101567, R21MH102646, R34MH086668, R34MH099311)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- social anxiety disorder, pharmacotherapy, antidepressants, treatment efficacy, treatment moderators, quality of life, therapeutic mechanisms
- MeSH terms
- Phobia, Social, Adult, Antidepressive Agents, Anxiety Disorders, Cognition, Humans, Monoamine Oxidase Inhibitors, Quality of Life, Randomized Controlled Trials as Topic, Treatment Outcome, Selective Serotonin Reuptake Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A meta-analysis of pharmacotherapy for social anxiety disorder: an examination of efficacy, moderators, and mediators. https://app.cochat.ai/papers/10.1080/14656566.2017.1285907
- The paper
- Curtiss, J., Andrews, L., Davis, M., Smits, J., & Hofmann, S. G. (2017). A meta-analysis of pharmacotherapy for social anxiety disorder: an examination of efficacy, moderators, and mediators. Expert Opinion on Pharmacotherapy. https://doi.org/10.1080/14656566.2017.1285907
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.